Skip to content
    Oaktree logo

    Oaktree

    Los Angeles, California, United StatesFounded 1995
    www.oaktreecapital.comLinkedIn
    PropTechInfrastructure & CloudHealthcare

    Oaktree Capital Management is a global alternative investment management firm founded in 1995 and headquartered in Los Angeles. The firm specializes in credit, private equity, real estate, and distressed-debt strategies, and is widely recognized as the world's largest distressed-debt investor. Oaktree is majority-owned by Brookfield Asset Management.

    Average disclosed round size is $440.2M (across 31 rounds with reported amounts).

    Find people at Oaktree on Goldilocks AI

    Portfolio

    26

    Fund Size

    $16B

    Top Stage

    Unknown

    Last 12 Mo

    0

    Team

    Bruce Karsh

    Bruce Karsh

    Co-Chair and Chief Investment Officer

    Armen Panossian

    Armen Panossian

    Co-Chief Executive Officer

    Howard Marks

    Howard Marks

    Co-Chair

    Jay Ghiya

    Jay Ghiya

    Chief Operating Officer

    John Frank

    John Frank

    Vice Chairman

    Karly Lancaric

    Karly Lancaric

    Chief Financial Officer

    Robert O'Leary

    Robert O'Leary

    Co-Chief Executive Officer

    AM

    Andrew Moir

    Managing Director

    AT

    Atsushi Takeiri

    Managing Director

    BB

    Brendan Beer

    Managing Director and Co-Portfolio Manager

    CL

    Christina Lee

    Managing Director and Co-Portfolio Manager

    DP

    Danielle Poli

    Managing Director and Co-Portfolio Manager, Global Credit

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    35 investments
    CompanyRoundAmountDate
    SHINE Technologies logoSHINE TechnologiesUnknown$240MJan 2026
    Unblocked logoUnblockedSeries A$20MMay 2025
    Unblocked logoUnblockedSeries A$20MMay 2025
    Fruitist logoFruitistGrowth$150MMar 2024
    Banca Progetto logoBanca ProgettoUnknown$1.7BFeb 2024
    Sumup logoSumupGrowth$624MJun 2022
    BioXcel Therapeutics logoBioXcel TherapeuticsSeries D$260MApr 2022
    Unblocked logoUnblockedSeed$10MJan 2022
    Unblocked logoUnblockedSeed—Jan 2022
    BYJU'S logoBYJU'SSeed$1BJan 2022
    BioXcel Therapeutics logoBioXcel TherapeuticsUnknown$260MJan 2022
    Aspiration logoAspirationUnknown—Dec 2021
    Elevate Brands logoElevate BrandsSeries B$55MNov 2021
    Thrasio logoThrasioSeries D$1BOct 2021
    Win Brands logoWin BrandsUnknown$50MFeb 2021
    Thrasio logoThrasioGrowth$750MFeb 2021
    Shoals Technologies Group logoShoals Technologies GroupIpo$2.2BJan 2021
    Thrasio logoThrasioSeries D$1BJan 2021
    Quid logoQuidGrowth$320MNov 2020
    REEF Technology logoREEF TechnologyUnknown$700MJan 2020
    Healthcare.com logoHealthcare.comSeries B$18MNov 2019
    Mission Lane logoMission LaneSeries A$200MSep 2019
    Cure.fit logoCure.fitSeries D$75MJun 2019
    Curefit logoCurefitSeries D$120MJun 2019
    Cure.fit logoCure.fitSeries D$120MJan 2019
    Page 1 of 2

    Top Co-Investors

    Chiratae Ventures5 shared
    Accel5 shared
    Kalaari Capital5 shared
    Tiger Global Management, LLC4 shared
    Dapper Labs4 shared
    InnoVen Capital4 shared
    Advent International3 shared
    Upper903 shared
    Western Technology Investment3 shared
    Unilever Ventures3 shared
    EPIQ Capital Group3 shared
    B Capital3 shared
    M133 shared
    BAM Ventures3 shared
    Qatar Investment Authority2 shared
    Silver Lake2 shared
    The Invus Group, LLC2 shared
    Apollo Global Management, Inc.2 shared
    BlackRock Private Equity Partners2 shared
    Amplify Partners2 shared

    Last updated: 20 October 2026